Vanda Pharmaceuticals Earnings Preview

Vanda Pharmaceuticals VNDA is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement.

Analysts estimate that Vanda Pharmaceuticals will likely report an Earnings Per Share (EPS) of $0.16

Vanda Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat on EPS by 21.43%, which was followed by a 8.5% drop in the share price the next day.

Here's a look at Vanda Pharmaceuticals's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate 0.14 0.15 0.14 0.09
EPS Actual 0.17 0.15 0.15 0.11
Price Change % -8.5% 5.61% 21.16% 8.97%

Stock Performance

Shares of Vanda Pharmaceuticals were trading at $19.28 as of November 01. Over the last 52-week period, shares are up 58.04%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here


Analyst Ratings




Posted In: EarningsBZI-EP